Aardvark Therapeutics, Inc. (AARD)

Accolade Statistics

Total Valuation

AARD has a market cap or net worth of $263.17 million. The enterprise value is $112.64 million.

Market Cap	263.17M
Enterprise Value	112.64M

Important Dates

The next estimated earnings date is Thursday, August 14, 2025, after market close.

Earnings Date	Aug 14, 2025
Ex-Dividend Date	n/a

Share Statistics

AARD has 21.70 million shares outstanding. The number of shares has increased by 59.04% in one year.

Current Share Class	21.70M
Shares Outstanding	21.70M
Shares Change (YoY)	+59.04%
Shares Change (QoQ)	+224.75%
Owned by Insiders (%)	14.49%
Owned by Institutions (%)	16.13%
Float	11.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.75
P/TBV Ratio	1.75
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 25.86, with a Debt / Equity ratio of 0.00.

Current Ratio	25.86
Quick Ratio	25.31
Debt / Equity	0.00
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -34.70% and return on invested capital (ROIC) is -24.18%.

Return on Equity (ROE)	-34.70%
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	-24.18%
Return on Capital Employed (ROCE)	-20.58%
Revenue Per Employee	n/a
Profits Per Employee	-$1.26M
Employee Count	22
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	12.27
200-Day Moving Average	n/a
Relative Strength Index (RSI)	46.16
Average Volume (20 Days)	40,948

Short Selling Information

The latest short interest is 663,811, so 3.06% of the outstanding shares have been sold short.

Short Interest	663,811
Short Previous Month	622,292
Short % of Shares Out	3.06%
Short % of Float	5.94%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-31.08M
Pretax Income	-13.85M
Net Income	-27.72M
EBITDA	-31.07M
EBIT	-31.08M
Earnings Per Share (EPS)	-$4.40

Balance Sheet

The company has $151.26 million in cash and $726,000 in debt, giving a net cash position of $150.53 million or $6.94 per share.

Cash & Cash Equivalents	151.26M
Total Debt	726,000
Net Cash	150.53M
Net Cash Per Share	$6.94
Equity (Book Value)	150.69M
Book Value Per Share	6.95
Working Capital	148.58M

Cash Flow

In the last 12 months, operating cash flow was -$27.29 million and capital expenditures -$104,000, giving a free cash flow of -$27.39 million.

Operating Cash Flow	-27.29M
Capital Expenditures	-104,000
Free Cash Flow	-27.39M
FCF Per Share	-$1.26

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

AARD does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-59.04%
Shareholder Yield	-59.04%
Earnings Yield	-10.53%
FCF Yield	-10.41%

Analyst Forecast

The average price target for AARD is $33.00, which is 170.94% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$33.00
Price Target Difference	170.94%
Analyst Consensus	Strong Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1